Besides, we found that DDK1 was associated with poor prognosis of NSCLC patients and positively correlated to circulating MAPS in this study, which have been reported to promote tumor progression and negatively regulate antitumor immunity [49]. The gene discussed is C3orf62; the disease is non-small cell lung carcinoma.